LBT.ASX
Weekly wrap: markets enter a new era after incredible volatility
After an absolutely hectic and volatile week on the world’s share markets, it is tempting to say well, that’s over now and things have settled down. On the surface that may be true, particularly when you consider that the ASX 200 is only down 2% for the week but it doesn’t factor in the fact […]
LBT Innovations signs $4.1m deal with AstraZeneca for supply of APAS Independence kits
Australian medical technology company LBT Innovations (ASX: LBT) has signed a $4.1 million deal to supply its APAS (automated plate assessment system) Independence kits plus support and maintenance services to global biopharmaceutical company and development partner AstraZeneca. The seven-year contract will see the first five instruments supplied and installed across a number of AstraZeneca’s large […]
Market wrap: banks drag ASX 200 lower but miners provide strength
Investors continued to bail out of bank stocks, dragging the ASX 200 index lower despite some positive news for the big miners on the back of a stronger copper price. The strong rally in bank share prices that saw most of them hit multi-year highs just a week ago is nothing but a memory now, […]
LBT Innovations confirms APAS PharmaQC ready for sale to global biopharma markets
LBT Innovations (ASX: LBT) has announced that its APAS (Automated Plate Assessment System) PharmaQC technology for automated imaging, analysis and interpretation of microbiology culture plates is ready for sale to global markets. The announcement follows the completion of primary validation testing, the final stage in the commercialisation process with product development partner AstraZeneca. Testing was […]